Loading
A phase 3 trial in colorectal cancer, run by Kyungpook National University Hospital, active but no longer recruiting.
Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer is a phase 3, randomised interventional study registered as NCT03426904 by Kyungpook National University Hospital, with a registry enrolment figure of 708 participants, started 2020-10-23 and due to reach its primary completion in 2028-12-28. Interventions recorded: Neoadjuvant FOLFOX; Conventional adjuvant FOLFOX. Conditions listed: Colon Cancer. Primary outcome: Relapse free survival after randomization. Colorectal eligibility wording from the registry: "* Pathologically confirmed colon adenocarcinoma (\> 15 cm from the anal verge)". Sites: South Korea. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.